New pill could ease painful skin condition
NCT ID NCT06799000
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests an oral drug called remibrutinib in 588 people with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps. The study compares two doses of the drug against a placebo over 68 weeks. The main goal is to see if the drug reduces the number of inflamed nodules and abscesses by at least half after 16 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
remibrutinib (an oral drug that targets inflammation)
What this could lead to
If it works, this could provide a new oral treatment option for people with moderate to severe hidradenitis suppurativa, reducing painful flare-ups and improving quality of life.
What could go wrong
This is a phase 3 trial, but results are not yet available. The drug may not work better than placebo, and side effects are possible. It is not a cure, and ongoing treatment may be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Research Experts
Nashville, Tennessee, 37211, United States
-
Arkansas Research Trials
North Little Rock, Arkansas, 72117, United States
-
Bellaire Dermatology Associates
Bellaire, Texas, 77401, United States
-
Care Access Hoboken
Hoboken, New Jersey, 07030, United States
-
Cheryl Effron MD Inc
Anaheim, California, 92807, United States
-
Clinical Trials Research Institute
Thousand Oaks, California, 91320, United States
-
Dawes Fretzin Clinical Rea Group
Indianapolis, Indiana, 46256, United States
-
Dermat. and Adv. Aesthetics
Lake Charles, Louisiana, 70605, United States
-
Equity Medical LLC
Bowling Green, Kentucky, 42104, United States
-
Essential Medical Research
Tulsa, Oklahoma, 74137, United States
-
Florida Academic Centers Research and Education LLC
Coral Gables, Florida, 33134, United States
-
Forest Hills Dermatology Group
New York, New York, 10003, United States
-
Gwinnett Clinical Research Center
Snellville, Georgia, 30078, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202-2689, United States
-
Howard University College of Medicine
Washington D.C., District of Columbia, 20060, United States
-
Icahn School Of Med At Mount Sinai
New York, New York, 10029, United States
-
Illinois Dermatology Institute
Chicago, Illinois, 60602, United States
-
Immunology-Rheumatology Research
Suwanee, Georgia, 30024, United States
-
Johnson Dermatology
Fort Smith, Arkansas, 72916, United States
-
Medical Dermatology Specialists
Phoenix, Arizona, 85006, United States
-
Medical University of South Carolina MUSC
Charleston, South Carolina, 29425, United States
-
Michigan Center for Rsrch Company
Clarkston, Michigan, 48346, United States
-
Novartis Investigative Site
Caba, Buenos Aires, C1119ACN, Argentina
-
Novartis Investigative Site
CABA, Buenos Aires, C1425BEA, Argentina
-
Novartis Investigative Site
Rosario, Santa Fe Province, 2000, Argentina
-
Novartis Investigative Site
CABA, C1428DZF, Argentina
-
Novartis Investigative Site
Phillip, Australian Capital Territory, 2606, Australia
-
Novartis Investigative Site
Sydney, New South Wales, 2010, Australia
-
Novartis Investigative Site
Westmead, New South Wales, 2145, Australia
-
Novartis Investigative Site
Melbourne, Victoria, 3004, Australia
-
Novartis Investigative Site
Parkville, Victoria, 3050, Australia
-
Novartis Investigative Site
Sofia, 1407, Bulgaria
-
Novartis Investigative Site
Stara Zagora, 6000, Bulgaria
-
Novartis Investigative Site
Surrey, British Columbia, V3V 0C6, Canada
-
Novartis Investigative Site
St. John's, Newfoundland and Labrador, A1E 1V4, Canada
-
Novartis Investigative Site
Hamilton, Ontario, L8L 3C3, Canada
-
Novartis Investigative Site
Richmond Hill, Ontario, L4C 9M7, Canada
-
Novartis Investigative Site
Québec, Quebec, G1W 4R4, Canada
-
Novartis Investigative Site
Saint-Jérôme, Quebec, J7Z 7E2, Canada
-
Novartis Investigative Site
Fuzhou, Fujian, 350025, China
-
Novartis Investigative Site
Guangzhou, Guangdong, 510000, China
-
Novartis Investigative Site
Wuhan, Hubei, 430022, China
-
Novartis Investigative Site
Changsha, Hunan, 410008, China
-
Novartis Investigative Site
Changchun, Jilin, 130021, China
-
Novartis Investigative Site
Shenyang, Liaoning, 110011, China
-
Novartis Investigative Site
Xian, Shanxi, 710004, China
-
Novartis Investigative Site
Chengdu, Sichuan, 610041, China
-
Novartis Investigative Site
Ürümqi, Xinjiang, 830001, China
-
Novartis Investigative Site
Ningbo, Zhejiang, 315016, China
-
Novartis Investigative Site
Beijing, 100144, China
-
Novartis Investigative Site
Jinan, 250012, China
-
Novartis Investigative Site
Barranquilla, Atlántico, 080002, Colombia
-
Novartis Investigative Site
Bogota, Cundinamarca, 110221, Colombia
-
Novartis Investigative Site
Cali, Valle del Cauca Department, 760032, Colombia
-
Novartis Investigative Site
Medellín, 050034, Colombia
-
Novartis Investigative Site
Roskilde, 4000, Denmark
-
Novartis Investigative Site
Langenau, Baden-Wurttemberg, 89129, Germany
-
Novartis Investigative Site
Darmstadt, Hesse, 64283, Germany
-
Novartis Investigative Site
Dresden, Saxony, 01307, Germany
-
Novartis Investigative Site
Halle, Saxony-Anhalt, 06108, Germany
-
Novartis Investigative Site
Berlin, 10789, Germany
-
Novartis Investigative Site
Berlin, 13353, Germany
-
Novartis Investigative Site
Bochum, 44791, Germany
-
Novartis Investigative Site
Bonn, 53105, Germany
-
Novartis Investigative Site
Erlangen, 91054, Germany
-
Novartis Investigative Site
Hamburg, 20095, Germany
-
Novartis Investigative Site
Hanover, 30159, Germany
-
Novartis Investigative Site
Kiel, 24105, Germany
-
Novartis Investigative Site
Mainz, 55131, Germany
-
Novartis Investigative Site
Münster, 48149, Germany
-
Novartis Investigative Site
Chaïdári, 124 62, Greece
-
Novartis Investigative Site
Heraklion Crete., 715 00, Greece
-
Novartis Investigative Site
Thessaloniki, 546 43, Greece
-
Novartis Investigative Site
Ancona, AN, 60126, Italy
-
Novartis Investigative Site
Brescia, BS, 25123, Italy
-
Novartis Investigative Site
Catania, CT, 95123, Italy
-
Novartis Investigative Site
Cona, FE, 44124, Italy
-
Novartis Investigative Site
Florence, FI, 50122, Italy
-
Novartis Investigative Site
Rozzano, MI, 20089, Italy
-
Novartis Investigative Site
Modena, MO, 41124, Italy
-
Novartis Investigative Site
Pisa, PI, 56126, Italy
-
Novartis Investigative Site
Roma, RM, 00168, Italy
-
Novartis Investigative Site
Torino, TO, 10126, Italy
-
Novartis Investigative Site
Muar town, Johor, 84000, Malaysia
-
Novartis Investigative Site
George Town, Pulau Pinang, 10450, Malaysia
-
Novartis Investigative Site
Kuching, Sarawak, 93586, Malaysia
-
Novartis Investigative Site
Kuala Terengganu, Terengganu, 20400, Malaysia
-
Novartis Investigative Site
Kuala Lumpur, 59100, Malaysia
-
Novartis Investigative Site
Guadalajara, Jalisco, 44340, Mexico
-
Novartis Investigative Site
Guadalajara, Jalisco, 44650, Mexico
-
Novartis Investigative Site
Cuauhtémoc, Mexico City, 06100, Mexico
-
Novartis Investigative Site
Chihuahua City, 31203, Mexico
-
Novartis Investigative Site
Bydgoszcz, 85-094, Poland
-
Novartis Investigative Site
Gdansk, 80-214, Poland
-
Novartis Investigative Site
Lodz, 90-436, Poland
-
Novartis Investigative Site
Almada, 2805-267, Portugal
-
Novartis Investigative Site
Braga, 4710243, Portugal
-
Novartis Investigative Site
Coimbra, 3004-561, Portugal
-
Novartis Investigative Site
Lisbon, 1169-050, Portugal
-
Novartis Investigative Site
Lisbon, 1998-018, Portugal
-
Novartis Investigative Site
Porto, 4099-001, Portugal
-
Novartis Investigative Site
Bratislava, 811 09, Slovakia
-
Novartis Investigative Site
Bratislava, 813 69, Slovakia
-
Novartis Investigative Site
Prešov, 080 01, Slovakia
-
Novartis Investigative Site
Trnava, 917 02, Slovakia
-
Novartis Investigative Site
Raslouw Centurion, Gauteng, 0157, South Africa
-
Novartis Investigative Site
Soweto, Gauteng, 2013, South Africa
-
Novartis Investigative Site
Cape Town, 7505, South Africa
-
Novartis Investigative Site
Durban, 4058, South Africa
-
Novartis Investigative Site
Cadiz, Andalusia, 11009, Spain
-
Novartis Investigative Site
Badalona, Barcelona, 08916, Spain
-
Novartis Investigative Site
Sabadell, Barcelona, 08208, Spain
-
Novartis Investigative Site
Barcelona, Catalonia, 08003, Spain
-
Novartis Investigative Site
Manises, Valencia, 46940, Spain
-
Novartis Investigative Site
Valencia, Valencia, 46017, Spain
-
Novartis Investigative Site
Madrid, 28009, Spain
-
Novartis Investigative Site
Madrid, 28046, Spain
-
Novartis Investigative Site
Valencia, 46014, Spain
-
Novartis Investigative Site
Basel, 4031, Switzerland
-
Novartis Investigative Site
Bern, 3010, Switzerland
-
Novartis Investigative Site
Zurich, 8091, Switzerland
-
Novartis Investigative Site
Kaohsiung City, 83301, Taiwan
-
Novartis Investigative Site
Taipei, 10002, Taiwan
-
Novartis Investigative Site
Taoyuan, 33305, Taiwan
-
Olive View UCLA Medical Center
Sylmar, California, 91342, United States
-
OnSite Clinical Solutions LLC
Huntersville, North Carolina, 28078, United States
-
Physioseq
Sacramento, California, 95826, United States
-
RFSA Dermatology
San Antonio, Texas, 78213, United States
-
Revival Research Institute
Troy, Michigan, 48084, United States
-
Revival Research Institute LLC
Evans, Georgia, 30809, United States
-
Skinsearch of Rochester Inc
Rochester, New York, 14623, United States
-
UP Medical Center H System
Pittsburgh, Pennsylvania, 15213-3403, United States
-
Unity Clinical Research
Oklahoma City, Oklahoma, 73118, United States
-
University of MiamiHealth System
Miami, Florida, 33125, United States
-
University of Mississippi Med Ctr
Jackson, Mississippi, 39216, United States
-
Virginia Clinical Research
Norfolk, Virginia, 23507, United States
-
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27104, United States
-
Ziaderm Research LLC
North Miami Beach, Florida, 33162, United States